Press release
Bile Duct Cancer Market To Demonstrate a Phenomenal Growth at Rising CAGR 9.2% up to 2023 | Along with Top 10 Industry Prestigious Players
Bile Duct Cancer Market
Bile duct cancer or cholangiocarcinoma is a rare form of cancer occurring due to uncontrolled growth of abnormal cells within the bile ducts, which can affect surrounding healthy tissues and organs like pancreas and can eventually spread to other areas in the body. Bile duct cancer can be diagnosed by imaging tests, blood test, abdominal ultrasound, biopsy of the affected tissue and other methods.
According to the American cancer society, 30,200 estimated deaths have occurred in U.S in 2017 and 42,220 new cases of intrahepatic bile duct cancer are expected to occur in U.S. in 2018 .The growing prevalence of bile duct cancer is likely to boost the market in forecast period.
The market is going to observe a steady growth due to increasing prevalence of the disease, investment in R&D by key market players like Pfizer Inc., Bristol-Myers Squibb Company. Whereas, the risk factors that may restrain the market growth are high treatment cost, treatment related side effects, lack of awareness in the developing markets and treatment related side effects.
The global bile duct cancer market accounted to USD 154.5 million in 2017 and is forecasted to demonstrate a radial growth by 2018, global Bile Duct market is expected to grow at a CAGR of 9.1% during forecasted period 2018-2023.
Get PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/4741 .
Key players for Global Bile Duct Cancer Market
The key players for the Global Bile Duct Cancer Market are Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd (Europe), Teva Pharmaceutical Industries Ltd.(Israel), Eli Lilly and Company(U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), Pfizer Inc.(US), Johnson & Johnson (U.S.), Celgene Corporation(U.S.) and others.
Competitive Landscape of Global Bile Duct Cancer Market
The Global Bile Duct Cancer Market appears to be highly fragmented and highly competitive due to new product launches and increasing clinical research. The key player have developed strategic approaches to increase their foothold in this market. The major key players are located in North America region like Pfizer Inc., Bristol-Myers Squibb Company increasing the market revenue in the region.
Pfizer Inc. is an American Global research based pharmaceutical company with its headquarter in New York City. Pfizer is engaged in developing, producing and manufacturing healthcare products. The major sector includes immunology, oncology, cardiology, endocrinology, and neurology. Pfizer Inc. has two business segments, Pfizer Innovative Health and Pfizer Essential Health. The company has its market in over 125 countries.
Pfizer announced completion of its license agreement with Basilea Pharmaceutica AG in July 2017,which help the company in obtaining commercialization rights to CRESEMBA in Europe (with exception from Nordic countries).Further, Pfizer gained commercialization rights of CRESEMBA in Italy, Germany, Austria, France and United kingdom.Pfizer successfully launched CRESEMBA in Spain. More launches are expected of the product in emerging markets in 2018.
Eli Lilly and Company is a leading Global pharmaceutical corporation headquartered in Indiana, U.S. with its product sold in over 120 countries and manufacturing plants located in 17 countries. The company operates in two segments human pharmaceutical and animal healthcare. The human pharmaceutical segment includes immunology products, endocrinology products, neuroscience products, oncology products, and cardiovascular products. The Company's major oncology products include Altima, Cyramza, Gemzar, and Portrazza.
In March 2018, Eli Lilly and Company announced successful completion of its primary phase 3 REACH-2 trial study in trial biomarker selected population for CYRAMZA (ramucirumab), a single agent in the second-line treatment of people with hepatocellular carcinoma (HCC).The trial met its primary and secondary endpoint. This study proves beneficial for the company as CYRAMZA has demonstrated survival benefits in four regressive tumor type and as single agent in hepatocellular carcinoma.
Get an Exclusive Discount on Report @ https://www.marketresearchfuture.com/check-discount/4741 .
Regional Analysis of Global Bile Duct Cancer Market
The American region consisting of North America and South America dominates the global bile duct cancer market. As per the reports published by cholangiocarcinoma foundation in 2017, every year about 6,000 people suffer from bile duct cancer in the United States.
Europe is the second largest bile duct cancer market owing increasing incidence of bile duct cancer, advanced in cancer related discoveries and ongoing innovations for treating cancer in early stages.
Asia Pacific is the rapidly growing region for the bile duct cancer market due to the presence of a huge patient population, continuously developing economies like India and China, and presence of huge growth prospectus in the market.
The Middle East & Africa has the least share in the global bile duct cancer market due to the presence of poor economy and lack of awareness mainly in Africa region.
Some Brief Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
TOC Continued…
Get Your Customized Report @ https://www.marketresearchfuture.com/enquiry/4741 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bile Duct Cancer Market To Demonstrate a Phenomenal Growth at Rising CAGR 9.2% up to 2023 | Along with Top 10 Industry Prestigious Players here
News-ID: 1087789 • Views: …
More Releases from Market Research Future
Digital Education Content Market to Reach USD 1084.46 Billion by 2034, Driven by …
The digital education content market is expanding rapidly as the global education system continues its shift toward online and blended learning models. This market includes a wide variety of digital learning materials, such as e-books, interactive modules, video lessons, virtual simulations, and gamified assessments, which are designed to enhance teaching effectiveness and learner engagement across age groups and industries.
The demand for digital content is rising in both academic and corporate…
TV and OTT Programs Market to Reach USD 1109.59 Billion by 2034, Driven by Digit …
The TV and Over-the-Top (OTT) programs market is undergoing a major transformation as audiences increasingly shift from traditional broadcast models to digital streaming platforms. With the rise of high-speed internet and mobile devices, consumers now demand on-demand, personalized content experiences that OTT platforms are well-positioned to deliver.
OTT services-ranging from subscription-based video platforms to ad-supported streaming apps-have disrupted conventional television by offering flexible access to a wide variety of content. This…
AR/VR Software Market to Surpass USD 699.20 Billion by 2034, Fueled by Immersive …
The augmented reality (AR) and virtual reality (VR) software market is experiencing explosive growth as businesses and consumers alike embrace immersive technologies for everything from entertainment and education to training and design. AR/VR software enables the creation, deployment, and management of digital experiences that blend or simulate physical environments in real time.
The rapid evolution of computing power, wearable devices, and 5G connectivity has made it possible to deliver high-quality immersive…
Business Information Market to Reach USD 76.51 Billion by 2034, Fueled by Data-D …
The business information market is growing rapidly as organizations across industries increasingly depend on data to make informed strategic decisions. Business information encompasses a wide range of insights, including financial data, market trends, company profiles, industry reports, and competitive intelligence. These insights empower enterprises to assess risks, identify opportunities, and improve operational efficiency.
In a fast-paced digital economy, access to accurate and timely information has become a critical asset for businesses…
More Releases for Bile
Bile Duct Cancer Drugs Market Demand by 2025: QY Research
This recently published report examines the global Bile Duct Cancer Drugs market for the projected period of 7-years, i.e. between 2018 and 2025. The report highlights the accomplishments and opportunities lies in the market throughout the forecasted period. The report offers the thorough information about the overview and the scope of the global Bile Duct Cancer Drugs market along with its drivers, restraints, and trends. It also classifies the market…
Bile Duct Cancer Drugs and Companies Research 2023
Report Description
This report analyzes the bile duct cancer market by type (intrahepatic, extrahepatic), diagnosis (blood tests, abdominal imaging, surgery), by treatment (chemotherapy, radiotherapy), by end user (hospital& clinics, academic institutes); it also studies the top manufacturers in the market.
The bile duct cancer market is expected to grow at a CAGR of near about 9.2% during the forecast period.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3439013-bile-duct-cancer-market-research-report-global-forecast-till-2023
The major players in bile duct cancer…
Cholangiocarcinoma (Bile Duct Cancer) Treatment Market worth US$ 144.2 Million
In 2017, the global market for bile duct cancer treatments is anticipated to bring in revenues worth a little over US$ 168 Mn. Apart from rising incidence of bile duct cancer across the APAC and Middle East & Africa region, increasing healthcare spending is also expected to drive the demand for bile duct cancer treatments. Towards the end of 2025, the global bile duct cancer treatment market is projected to…
Global Bile Duct Cancer Market is Driven by Increase in Prevalence of Bile Duct …
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing…
Bile Duct Cancer Market Overview and Report forecast 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing…
Bile Duct Cancer Market Size – Industry Share Report 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing…
